PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE
PL9 is a Ligand Of Interest in 4TNJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4TNJ_PL9_a_409 | 3% | 34% | 0.383 | 0.755 | 1.02 | 1.55 | 3 | 10 | 0 | 0 | 82% | 1 |
| 4TNJ_PL9_d_406 | 2% | 35% | 0.385 | 0.68 | 1.02 | 1.53 | 2 | 14 | 0 | 0 | 100% | 1 |
| 4TNJ_PL9_D_407 | 2% | 35% | 0.388 | 0.678 | 1.03 | 1.52 | 3 | 13 | 0 | 0 | 100% | 1 |
| 4TNJ_PL9_A_406 | 1% | 35% | 0.432 | 0.694 | 0.98 | 1.56 | 4 | 10 | 0 | 0 | 82% | 1 |
| 4TNJ_PL9_j_101 | 0% | 35% | 0.37 | 0.493 | 1 | 1.56 | 1 | 7 | 0 | 0 | 64% | 1 |
| 4TNJ_PL9_J_101 | 0% | 34% | 0.541 | 0.433 | 1.02 | 1.56 | 1 | 7 | 0 | 0 | 64% | 1 |
| 3WU2_PL9_d_405 | 98% | 30% | 0.047 | 0.966 | 1.27 | 1.53 | 9 | 13 | 0 | 0 | 100% | 1 |
| 5WS6_PL9_D_405 | 97% | 37% | 0.055 | 0.967 | 0.69 | 1.76 | 2 | 21 | 0 | 0 | 100% | 1 |
| 5B5E_PL9_d_406 | 96% | 33% | 0.054 | 0.965 | 1.05 | 1.59 | 4 | 12 | 0 | 0 | 100% | 1 |
| 5GTI_PL9_d_405 | 96% | 36% | 0.053 | 0.962 | 0.64 | 1.86 | 2 | 22 | 0 | 0 | 100% | 1 |
| 5V2C_PL9_d_407 | 96% | 34% | 0.069 | 0.978 | 1.27 | 1.32 | 8 | 10 | 0 | 0 | 100% | 1 |
| 1VF5_PL9_Q_1305 | 98% | 4% | 0.062 | 0.984 | 3.4 | 2.39 | 21 | 16 | 32 | 0 | 100% | 1 |
